David LAPOINTE

Person

  • South San Francisco, CA, US

Patents Grantslast 30 patents

  • Information Patent Grant

    Heterocyclic inhibitors of ATR kinase

    • Patent number 11,434,233
    • Issue date Sep 6, 2022
    • Board of Regents, The University of Texas System
    • Maria Emilia Di Francesco
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Heterocyclic inhibitors of ATR kinase

    • Patent number 10,800,769
    • Issue date Oct 13, 2020
    • Board of Regents, The University of Texas System
    • Maria Emilia Di Francesco
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Heterocyclic inhibitors of ATR kinase

    • Patent number 10,392,376
    • Issue date Aug 27, 2019
    • Board of Regents, The University of Texas System
    • Maria Emilia Di Francesco
    • C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

  • Information Patent Application

    HETEROCYCLIC INHIBITORS OF ATR KINASE

    • Publication number 20210047311
    • Publication date Feb 18, 2021
    • Board of Regents, The University of Texas System
    • Maria Emilia DI FRANCESCO
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    HETEROCYCLIC INHIBITORS OF ATR KINASE

    • Publication number 20200102296
    • Publication date Apr 2, 2020
    • Board of Regents, The University of Texas System
    • Maria Emilia DI FRANCESCO
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    HETEROCYCLIC INHIBITORS OF ATR KINASE

    • Publication number 20190016713
    • Publication date Jan 17, 2019
    • Board of Regents, The University of Texas System
    • Maria Emilia DI FRANCESCO
    • C07 - ORGANIC CHEMISTRY